AMH and Ovarian Reserve — What the Numbers Actually Mean

Anti-Müllerian Hormone (AMH) is the most widely used marker of ovarian reserve, but it is also one of the most commonly misunderstood. This page explains what AMH measures, what it predicts and what it does not, the role of antral follicle count, and how reserve markers shape fertility planning.

1. What AMH is

Anti-Müllerian Hormone is produced by granulosa cells of small antral and pre-antral follicles. Serum AMH reflects the size of the remaining follicle pool — essentially, how many eggs are left in the ovaries. AMH is relatively stable across the menstrual cycle, so blood can be drawn any day. Levels decline progressively with age.

2. AMH interpretation by range

Approximate AMH categories: above 3.0 ng/ml — high (potential PCOS/high responder); 1.5–3.0 ng/ml — normal for reproductive-age women; 1.0–1.5 ng/ml — low-normal; 0.5–1.0 ng/ml — diminished ovarian reserve; below 0.5 ng/ml — severely diminished. Reference ranges vary by laboratory and assay; always interpret against the specific laboratory normal range.

3. AMH and age

AMH falls by approximately 0.05–0.1 ng/ml per year on average, accelerating after age 35. A 25-year-old with AMH 1.0 ng/ml is profoundly abnormal; a 42-year-old with AMH 1.0 ng/ml is age-appropriate. Always interpret AMH against the woman age — there is no single “low” number applicable across ages.

4. What AMH predicts

AMH reliably predicts the response to ovarian stimulation — the number of eggs that will be retrieved in an IVF cycle. High AMH predicts strong response (and OHSS risk). Low AMH predicts fewer eggs. AMH does NOT reliably predict pregnancy chance, miscarriage risk, or egg quality. A woman with low AMH at 32 still has 32-year-old egg quality.

5. Antral follicle count (AFC)

Transvaginal ultrasound counting follicles 2–10 mm in both ovaries, ideally on cycle day 2–5. Total AFC of 12–25 is normal; above 25 suggests PCOS; below 7 suggests diminished reserve. AFC and AMH together provide the most accurate ovarian reserve assessment — better than either alone.

6. Other reserve markers

Day 2–3 FSH below 10 mIU/ml is reassuring; above 10 suggests poor reserve. Day 2–3 estradiol above 60 pg/ml suggests poor response despite normal FSH. Inhibin B and clomiphene challenge test — older markers, rarely used now since AMH and AFC are more accurate. Ultrasound assessment of ovarian volume — supplementary.

7. Diminished reserve management

For low AMH/AFC, IVF protocols are adapted: gentler stimulation to avoid wasted eggs, longer pituitary suppression strategies in selected cases, dual stimulation in same cycle (DuoStim) for time-critical cases. CoQ10 (200–600 mg daily) and DHEA in selected cases — emerging evidence. Donor egg discussed when reserve is very low (AMH below 0.3) and prior cycles have failed.

8. AMH in clinical decisions

Younger women planning to delay pregnancy — AMH informs egg-freezing timing. Endometriosis or fibroid patients before surgery — AMH baseline informs whether to operate or preserve fertility first. PCOS — AMH helps confirm diagnosis. Premature ovarian insufficiency — very low AMH supports diagnosis. AMH is one tool among several — never the sole basis for major fertility decisions.

Frequently Asked Questions

Individualised IVF and fertility planning with honest, evidence-based counselling — and realistic expectations from the very first consultation.

Book a consultation

Dr. Priyadatt Patel

Senior Gynecologist · Advanced Laparoscopic Surgeon · IVF and Endometriosis Programme Lead

MS OBGyn · Pregnancy Care · Advanced Gynaecological Ultrasound · Fertility Preservation

ESHRE / ESGE / AAGL / ASRM guideline-aligned practice. 3D Karl Storz precision technique. Fertility-preservation-first philosophy. Evidence-based decisions, honest counselling, long-term outcomes orientation.